(PharmaNewsWire.Com, November 16, 2017 ) The Global Chondroplasty Market Research Report provides detailed analysis of the key regional market status of the chondroplasty Industry.
The global Chondroplasty Market is expected to reach US$ 14.8 billion by 2023, and the market is projected to grow at a CAGR of ~ 7.2 % during the forecast period 2017-2023.
Chondroplasty is a surgery of damaged cartilage with an aim to reduce friction in the joint such as knee joint. In healthy condition articular cartilage which covers the end of the bones that form the joint is smooth and provides low friction surface for the joint structures. However in conditions such as arthritis, trauma, injuries etc. it becomes rough and damaged causing pain and swelling. Joint cartilage once damaged naturally heals poorly in most cases. Chondroplasty is performed to decrease complications, risks, and recovery time. The purpose of Chondroplasty is to remove away the damaged joint surface. The success rate of chondroplasty is about 70%. The drawback of Chondroplasty is that the new growth is not true cartilage/hyaline. Traditional chondroplasty is done by mechanical means such as shavers but has deleterious effects such as fine surface fibrillation, subchondral bleeding and formation of fibrocartilage, which is not as functional as normal hyaline cartilage. Radiofrequency ablation chondroplasty is the latest development and the most non-invasive chondroplasty. It uses radiofrequency waves for welding cracks together in the cartilage. The market drivers for chondroplasty are increasing geriatric population, growing screening for joint and orthopaedic defects, rising number of accidents & trauma cases, growing sports culture, rising awareness and growing income of people. The market restraints are the risks associated with surgery such as bleeding, pain, infection, cost considerations, poor healing in some cases, etc.
The global chondroplasty market has been segmented on the basis of types, anatomy, instruments and end users.
Based on types, the market has been segmented as radiofrequency ablation chondroplasty, abrasion chondroplasty, atellar chondroplasty, meniscal repair, tissue removal, and others.
Based on anatomy, the market has been segmented as knee, shoulder, hip, and others.
Based on instruments, the market has been segmented as shavers, RF devices, arthroscope and others.
Based on the end users, the market has been segmented as hospitals & orthopedic clinics, academic & research and others.
Some of key players profiled in the report are B. Braun Melsungen AG, NuOrtho Surgical, Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, Nebula Inc., Gpcmedical, Osiris Therapeutics, Inc., Sklar Surgical Instruments, Stryker Corporation, and others.
The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new instruments and surgical techniques in the US drives the chondroplasty market. The good reimbursement scenario and the greater awareness in the developed regions drive the market.
Europe is the second largest market in the world due to high income and healthcare penetration.
Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.
4.6 Intensity Of Rivalry Global Chondroplasty Market, By Types
5.1 Introduction
5.2 Radiofrequency Ablation Chondroplasty
5.3 Abrasion Chondroplasty
5.4 Atellar Chondroplasty
5.5 Meniscal Repair
5.6 Tissue Removal
5.7 Others About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
